Visit frequency: First 3 months: every 24 weeks Maintenance phase: monthly or bi-monthly Each visit should include: Weight tracking Vitals and symptom check Adherence review Lab follow-up: Lipase for pancreatitis risk Kidney function for patients with hypertension or diabetes Thyroid function in at-risk patients Side effect protocols: Nausea, vomiting, diarrhea, and constipation should be managed with dietary advice, hydration plans, and OTC medications if appropriate
Sleep problems are not officially listed as a common side effect of Wegovy (semaglutide)
External resources For researchers and individuals committed to understanding how tirzepatide fits into a broader health strategy, SeekPeptides offers the most comprehensive resource available
All these supplements are conveniently available in our online dispensary, making it easy for you to obtain everything you need to support your health in one place
It's advisable to discuss planned schedule changes with your healthcare provider to ensure safe transition
Phase 1 and Early Trials The first human studies began in late 2019